Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.
- 1 January 1975
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 36 (1), 185-196
- https://doi.org/10.1161/01.res.36.1.185
Abstract
We systematically modified isoproterenol's chemical structure to reduce chronotropic, arrhythmogenic, and vascular side effects. Experiments on dogs showed that the resulting drug, dobutamine, had an inotropic efficacy as great as that of epinephrine due to a direct action on beta1 cardiac receptors. However, unlike epinephrine, dobutamine's effect on alpha and beta2 vascular receptors was slight. At equivalent inotropic doses, dobutamine had less than a fourth of the chronotropic effect of isoproterenol. Desmethylimipramine (DMI), which blocks the sympathetic nerve fiber uptake mechanism, had no effect on dobutamine's actions. In contrast, DMI antagonized dopamine's inotropic effect, and marked chronotropic and pressor responses occurred when we used doses of dopamine large enough to elicit a direct inotropic effect. Dobutamine increased the contractility of isolated cat papillary muscles more but the automaticity less than did isoproterenol. In ischemic dog hearts, dobutamine lacked significant arrhythmic activity, whereas dopamine, norepinephrine, and isoproterenol caused severe ectopic activity. In dogs with experimentally induced low cardiac contractility, low cardiac output, and hypotension, dobutamine produced dose-related increases in cardiac contractility and output, restored arterial blood pressure, and reduced total peripheral resistance slightly. In contrast, isoproterenol failed to restore blood pressure, had only a meager effect on cardiac contractility and output, cuased extreme tachycardia, and lowered peripheral resistance more than did dobutamine. Norepinephrine, which did not increase cardiac contractility or output as much as dobutamine, excessively elevated peripheral resistance and arterial blood pressure.Keywords
This publication has 10 references indexed in Scilit:
- CLINICAL CARDIOVASCULAR PHARMACOLOGY OF DOBUTAMINE A SELECTIVE INOTROPIC CATECHOLAMINEThe Lancet, 1974
- Effects of Dobutamine on Left Ventricular Performance, Coronary Dynamics, and Distribution of Cardiac Output in Conscious DogsJCI Insight, 1974
- Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dogAmerican Journal of Physiology-Legacy Content, 1973
- The inotropic and chronotropic effects of catecholamines on the dog heartThe Journal of Physiology, 1971
- REGIONAL DISTRIBUTION OF CATECHOLAMINES IN THE HEARTS OF VARIOUS SPECIES*Annals of the New York Academy of Sciences, 1969
- Release of tritiated noradrenaline from perfused rat hearts by sympathomimetic aminesCanadian Journal of Physiology and Pharmacology, 1968
- The treatment of cardiogenic shock. Part I. The nature of cardiogenic shockAmerican Heart Journal, 1967
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967
- Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failureAmerican Journal Of Medicine, 1965
- Myocardial Norepinephrine Concentration in ManNew England Journal of Medicine, 1963